InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Bradner James E.. Director active across 1 company, notably AMGEN INC. Aggregated, 5 reports have been logged. History available since 9 February 2024. The latest transaction was disclosed on 9 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Bradner James E. is a declarant linked to AMGEN INC, where he is EVP, Research and Development. Across 5 filings in total, the 5 sampled filings run from 2024-02-12 to 2026-02-10 and the modal transaction nature is Attribution, with buy and sell amounts of EUR 0 in this recent sample.